Efficacy and Safety of Olanzapine/Fluoxetine Combination vs Fluoxetine Monotherapy Following Successful Combination Therapy of Treatment-Resistant Major Depressive Disorder

This study assessed prevention of relapse in patients with treatment-resistant depression (TRD) taking olanzapine/fluoxetine combination (OFC). Patients with major depressive disorder (MDD) who failed to satisfactorily respond to ⩾2 different antidepressants for ⩾6 weeks within the current MDD episo...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunner, Elizabeth, Tohen, Mauricio, Osuntokun, Olawale, Landry, John, Thase, Michael E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207330/
https://www.ncbi.nlm.nih.gov/pubmed/24801768
http://dx.doi.org/10.1038/npp.2014.101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207330/
https://www.ncbi.nlm.nih.gov/pubmed/24801768
http://dx.doi.org/10.1038/npp.2014.101

Ejemplares similares